PubMed

Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.

Sfikakis PP, Markomichelakis N, Theodossiadis GP, Grigoropoulos V, Katsilambros N, Theodossiadis PG.

Diabetes Care. 2005 Feb;28(2):445-7. No abstract available. PMID: 15677814 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.

PKC-DMES Study Group.

Arch Ophthalmol. 2007 Mar;125(3):318-24.PMID: 17353401 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.PMID: 17151486 [PubMed - indexed for MEDLINE]Related articles

Surgical and other treatments of diabetic macular edema: an update.

Christoforidis JB, D'Amico DJ.

Int Ophthalmol Clin. 2004 Winter;44(1):139-60. Review. No abstract available. PMID: 14704528 [PubMed - indexed for MEDLINE]Related articles

Regression of vasoproliferative tumor with systemic infliximab.

Japiassú RM, Brasil OF, Cunha AL, de Souza EC.

Ophthalmic Surg Lasers Imaging. 2008 Jul-Aug;39(4):348-9.PMID: 18717448 [PubMed - indexed for MEDLINE]Related articles

[Successful treatment of cystoid macular edema with etanercept in a patient with rheumatoid arthritis associated panuveitis]

Fukuda K, Kumagai N, Nakamura H, Kubo M, Matsuzaki M, Nishida T.

Nippon Ganka Gakkai Zasshi. 2008 Jan;112(1):51-7. Japanese. PMID: 18240604 [PubMed - indexed for MEDLINE]Related articles

Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.

Richez C, Blanco P, Gin H, Schaeverbeke T.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):607. No abstract available. PMID: 17181936 [PubMed - indexed for MEDLINE]Related articles

Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Jan;56(1):13-20.PMID: 17195186 [PubMed - indexed for MEDLINE]Related articlesFree article

Infliximab as monotherapy in giant cell arteritis.

Uthman I, Kanj N, Atweh S.

Clin Rheumatol. 2006 Feb;25(1):109-10. Epub 2005 May 18. No abstract available. PMID: 15902519 [PubMed - indexed for MEDLINE]Related articles

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.

Arthritis Rheum. 2006 Dec;54(12):3782-9.PMID: 17133559 [PubMed - indexed for MEDLINE]Related articlesFree article

The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.

Kalden JR.

Isr Med Assoc J. 2000 Dec;2 Suppl:11-2. No abstract available. PMID: 11344856 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors.

Bodaghi B, Bui Quoc E, Wechsler B, Tran TH, Cassoux N, Le Thi Huong D, Chosidow O, Herson S, Piette JC, LeHoang P.

Ann Rheum Dis. 2005 Jun;64(6):962-4. No abstract available. PMID: 15897316 [PubMed - indexed for MEDLINE]Related articlesFree article

Infliximab treatment in psoriatic arthritis: our experience.

Rioda WT, Adorni G.

Acta Biomed. 2006 Aug;77(2):95-102.PMID: 17172189 [PubMed - indexed for MEDLINE]Related articlesFree article

Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.

Yanyali A, Aytug B, Horozoglu F, Nohutcu AF.

Am J Ophthalmol. 2007 Jul;144(1):124-6.PMID: 17601433 [PubMed - indexed for MEDLINE]Related articles

TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report.

Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F, Dibiase N, Alimonti A, Granata M.

Eur Rev Med Pharmacol Sci. 2005 Nov-Dec;9(6):373-8.PMID: 16479743 [PubMed - indexed for MEDLINE]Related articles

Treatment of therapy-resistant sarcoidosis with adalimumab.

Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, Benticuaga MN.

Clin Rheumatol. 2006 Jul;25(4):596-7. Epub 2005 Oct 25.PMID: 16247590 [PubMed - indexed for MEDLINE]Related articles

Partial resolution of diabetic macular oedema after systemic treatment with furosemide.

Ciardella AP.

Br J Ophthalmol. 2004 Sep;88(9):1224-5. No abstract available. PMID: 15317721 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.

Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P.

Am J Ophthalmol. 2006 Nov;142(5):794-99. Epub 2006 Sep 15.PMID: 16978576 [PubMed - indexed for MEDLINE]Related articles

Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema.

Strøm C, Sander B, Klemp K, Aiello LP, Lund-Andersen H, Larsen M.

Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3855-8.PMID: 16186374 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):83-6.PMID: 16539824 [PubMed - indexed for MEDLINE]Related articles